The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cardiology

• Publication date

  2016-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2016.05.006PMID 27288971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.

  2013cited by this paper
• Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association

  2013cited by this paper
• Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.

  2013cited by this paper
• Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction

  2013cited by this paper
• Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Biomarkers and diagnostics in heart failure.

  2013cited by this paper
• Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

  2012cited by this paper
• Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

  2010cited by this paper
• The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI‐heart failure (GISSI‐HF) trial

  2010cited by this paper
• Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.

  2010cited by this paper
• Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.

  2009cited by this paper
• Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.

  2009cited by this paper
• Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension.

  2009cited by this paper
• Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

  2009cited by this paper
• Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status.

  2008cited by this paper
• Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.

  2008cited by this paper
• Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

  2008cited by this paper
• Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.

  2007cited by this paper
• Natriuretic peptides.

  2007cited by this paper
• Association between anaemia and N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP): Findings from the Heart and Soul Study

  2007cited by this paper
• Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

  2007cited by this paper
• Effects of body mass index and age on N-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients.

  2007cited by this paper
• Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.

  2007cited by this paper
• Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists

  2006cited by this paper
• Is brain natriuretic peptide production decreased in obese subjects?

  2006cited by this paper
• Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.

  2006cited by this paper
• Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT‐ANP and BNP/NT‐proBNP

  2005cited by this paper
• Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

  2005cited by this paper
• Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study

  2005cited by this paper
• Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

  2004cited by this paper
• Relation of anemia to diastolic heart failure and the effect on outcome.

  2004cited by this paper
• Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

  2002cited by this paper
• Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.

  2001cited by this paper
• Natriuretic peptides.

  1998cited by this paper
• Expression of natriuretic peptide receptors in human adipose and other tissues

  1996cited by this paper
• Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure

  1994cited by this paper

• Lack of an association between first‐trimester concentration of mid‐regional pro‐atrial natriuretic peptide and risk of early‐onset preeclampsia <34 weeks' gestation

  2023cites this paper
• Role of biomarkers in the heart failure clinic

  2022cites this paper
• Comparison of probiotic yogurt and ordinary yogurt consumption on serum Pentraxin3, NT-proBNP, oxLDL, and ApoB100 in patients with chronic heart failure: a randomized, triple-blind, controlled trial.

  2020cites this paper
• Cardiac Biomarkers of Heart Failure in Chronic Kidney Disease.

  2020cites this paper
• Bedeutung von Biomarkern bei akuter Herzinsuffizienz

  2019cites this paper
• Bedeutung von Biomarkern bei akuter Herzinsuffizienz

  2019cites this paper
• Schwerpunkt : Biomarker in der Akutmedizin

  2019cites this paper
• Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.

  2018cites this paper
• Impact of pro-atrial natriuretic peptide in atrial fibrillation and stroke

  2017cites this paper
• Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population‐based prospective study

  2017cites this paper